Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration
Ophthalmology Retina · 2024
DOI: 10.1016/j.oret.2024.02.012 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Ophthalmology Retina, 2024. Verfasst von Reza Karkhaneh und 28 weiteren Autor:innen. Beteiligte Einrichtung: Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Biosimilar Pharmaceuticals, Receptors, Vascular Endothelial Growth Factor, Wet Macular Degeneration. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: CinnaGen Co.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Research Centre, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Ophthalmology, Eye Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Poostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Isfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
- Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Förderung
- CinnaGen Co
Zitieren
APA
Karkhaneh, R., Faghihi, H., Riazi-Esfahani, H., Abrishami, M., Bazvand, F., Ebrahimiadib, N., Johari, M., Akhlaghi, M., Shoeibi, N., Nowroozzadeh, M. H., Ansari Astaneh, M. R., Khojasteh, H., Imani Fooladi, M., Khodabande, A., Ghassemi, F., Khalili Pour, E., Zarei, M., Mirshahi, A., Fazel, F., …, & Ghasemi Falavarjani, K. (2024). Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.02.012
Vancouver
Karkhaneh R, Faghihi H, Riazi-Esfahani H, Abrishami M, Bazvand F, Ebrahimiadib N, et al. Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 2024. doi:10.1016/j.oret.2024.02.012
BibTeX
@article{Karkhaneh2024,
author = {Karkhaneh, Reza and Faghihi, Hooshang and Riazi-Esfahani, Hamid and Abrishami, Mojtaba and Bazvand, Fatemeh and Ebrahimiadib, Nazanin and Johari, Mohammadkarim and Akhlaghi, Mohammadreza and Shoeibi, Nasser and Nowroozzadeh, Mohammad Hossein and Ansari Astaneh, Mohammad Reza and Khojasteh, Hassan and Imani Fooladi, Marjan and Khodabande, Alireza and Ghassemi, Fariba and Khalili Pour, Elias and Zarei, Mohammad and Mirshahi, Ahmad and Fazel, Farhad and Ashraf, Hossein and Hosseini, Seyedeh Maryam and Dourandeesh, Maryam and Feghhi, Mostafa and Alizadeh, Yousef and Behboudi, Hassan and Azadi, Pejvak and Sabzvari, Araz and Kafi, Hamidreza and Ghasemi Falavarjani, Khalil},
title = {Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration},
journal = {Ophthalmology Retina},
year = {2024},
doi = {10.1016/j.oret.2024.02.012}
}
EUVIMED